The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLong Ideas - Questcor Pharmaceuticals (NASDAQ:QCOR) announced this morning that it can now start making money on the prescriptions of H.P. Acthar Gel that the company sells to … Continue Reading
Read now- Canadian drugmaker Valeant Pharmaceuticals (NYSE:VRX) has offered to purchase the entirety of Medicis Pharmaceuticals (NYSE:MRX) this morning for $2.6B, or $44 per share. On August … Continue Reading
Read nowLong Ideas - Since reporting 2Q earnings on August 2nd, Threshold Pharmaceuticals (NASDAQ:THLD) gained 25% and is on track to end the month around $8.70, a $.50 premium … Continue Reading
Read nowQuick Picks - The Australian diagnostics company Genetic Technologies (NASDAQ:GENE)(ASX:GTG) is giving up gains from Wednesday, down 6% on the day to $3.48. The middle of the week … Continue Reading
Read nowLong Ideas - In a press release after the markets closed on Thursday, Achillion Pharmaceuticals (NASDAQ:ACHN) announced that the company will be selling $41.8M in common stock to … Continue Reading
Read nowMost Popular - Stem Cells Inc, (NASDAQ:STEM), developer of stem cell-based treatments for spinal injuries, is up for the second day in a row Friday in pre-market trading … Continue Reading
Read nowLong Ideas - Forest Laboratories (NYSE:FRX) and partner Ironwood Pharmaceuticals (NASDAQ:IRWD) announced FDA approval of Linzess (generically known as linaclotide) for the treatment of irritable bowel syndrome with … Continue Reading
Read now
